How to keep muscle while losing fat on a GLP-1

The first time I used a GLP-1 it was semaglutide, and it worked. The weight came off. What I did not think about early enough was what kind of weight was leaving. On these drugs the scale falls fast and it feels like pure progress, but a real share of what comes off is muscle unless you do specific things to keep it. The good news is that the things that protect it are known, boring, and mostly in your control, including one lever most people never think of: how you dose the drug.

On a GLP-1, a large share of the weight you lose is lean mass, not just fat, because rapid weight loss always costs muscle. The drug does not target muscle, the speed does. Resistance training, protein around 1.6 to 2.2 g per kg, and a slower rate of loss protect it. A newer drug class that spares muscle directly is coming, but it is not here yet.

Why does a GLP-1 cost you muscle?

Start with the reassuring part: the drug is not attacking your muscle. The muscle loss is the ordinary tax of losing weight quickly. Any large, fast drop in body weight comes partly from lean tissue, and a GLP-1 just makes that drop bigger and faster than most people have managed before.

The numbers are real, though. In the semaglutide body-composition data, roughly 40% of the weight lost registered as lean mass on the scans, well above the rough 25% you would expect from a slower diet. So on a naive GLP-1 cut, close to four of every ten pounds can be lean tissue rather than fat.

Here is the honest other half, because it matters. In that same data the proportion of the body made of lean tissue actually went up, because fat fell so much faster than muscle. So body composition improved even as absolute lean mass dropped. That is the nuance the scare headlines skip. Losing some lean mass while getting leaner overall is not a catastrophe. Losing an avoidable amount of it, when a few habits would have kept it, is the mistake worth preventing.

The two levers that do most of the work

If you do nothing else, do these two.

Resistance training is the strongest signal you can send your body to hold onto muscle in a deficit. In the one trial that paired a GLP-1 with a structured exercise program, the people who trained lost fat and gained lean mass, while the drug-only group did not, and the combination cut body fat about twice as much as either alone. The exact modality matters far less than doing it, the same way it does with any exercise you will actually keep up. Lifting, bands, bodyweight, whatever you will still be doing in a year is the right one. The point is to load the muscle so the body has a reason to keep it.

Protein is the second lever, and it works best stacked on the first. Across the resistance-training literature, the benefit for lean mass climbs with protein up to about 1.6 g per kg of bodyweight per day, and most people optimizing for muscle retention aim for 1.6 to 2.2. On a GLP-1 this gets harder precisely when it matters most, because the drug kills your appetite, and protein is the macro people drop first when they are not hungry. That is the trap. Eating far less while protein also falls is how you turn a fat-loss drug into a muscle-loss drug. Hitting protein on a GLP-1 takes deliberate effort in a way it never did before the drug flattened your hunger. On top of those two levers, creatine is a cheap, well-evidenced adjunct that helps hold strength through a cut.

Does how you dose the drug matter?

This is the lever almost nobody talks about, and it is where the Year One idea of escalating gradually pays off directly. How fast you lose weight is partly a dose decision, and the rate of loss changes how much of it is muscle.

The cleanest evidence is not from GLP-1s at all. In trained athletes, losing weight slowly, around 0.7% of bodyweight per week, let them gain lean mass, while a faster cut left lean mass flat. Same total loss, different speed, different amount of muscle kept. On a GLP-1 the dose is one of the main dials on that speed. Push the dose hard and the scale drops fast and takes more muscle with it. Hold a moderate dose and the loss is slower, steadier, and easier to defend with training and protein.

This is the strategy I run now. I moved from semaglutide to a triple agonist, one that hits GLP-1, GIP, and glucagon receptors, and I hold it at a moderate dose reached slowly over months rather than pushing for the fastest possible loss. Part of that is tolerability, the side effects are far milder for me this way, but part of it is exactly this muscle question. A moderate dose leaves the loss slow enough that resistance training and protein can actually protect the lean tissue. Fast is not better here. Fast is how you end up smaller and weaker.

There is a second reason to keep the dose moderate, and it is about what happens when you stop. When I came off semaglutide, the hunger came back hard and I regained some of the weight. So this time I deliberately leave a little hunger in play rather than crushing it completely, which keeps the discipline and the eating habits live while I am on the drug. The muscle you protect and the habits you build under the drug are exactly what you keep when you taper down or come off, and coming off is where most people lose the plot, since most of the weight tends to come back after stopping. The drug is a tool you build habits under, not a crutch that does the work for you. None of this is medical advice, and dose changes belong in a conversation with whoever manages your prescription, not a blog.

The frontier: drugs that spare muscle directly

There is real pharmacology aimed at this problem now. The most striking is bimagrumab, an antibody that blocks the activin receptor, a pathway that limits muscle growth. In a 2026 trial, bimagrumab combined with semaglutide kept 92% of the weight loss as fat and even added lean mass, against the roughly 7% lean loss seen with semaglutide alone. That is a fundamentally different kind of weight loss, fat down and muscle up at the same time.

Temper it, though. It is early, it is investigational, and one large program studying the same drug was recently halted, so the picture is not clean. This is a compound to watch, not one to chase. For now the durable version of muscle-sparing weight loss is not a second drug. It is resistance training, protein, and a rate of loss you actually control.

What to track so you know it is working

You cannot manage what you cannot see, and the scale is worse than useless here because it applauds muscle loss and fat loss equally. Track the things that separate them. Your strength in a couple of key lifts is the cheapest muscle gauge there is: if your working weights hold or climb while you lose weight, your muscle is intact. Your waist falling while your weight barely moves is the fat-loss signal the scale hides. And a consistent body-fat estimate over months tells you the composition story the single number never will.

That pattern, weight down slowly, waist down, strength holding, is exactly the recomposition the scale cannot show you, and it is the whole reason the body composition tracker in the Operating System bundle plots weight, waist, and a body-fat estimate together with your key lifts, so muscle loss shows up early instead of hiding behind a falling scale. On a GLP-1 that early warning is the difference between a recomp and a shrink.

Pick your one resistance-training habit, set a protein number you will actually hit, and hold the drug at a dose that lets the loss stay slow enough to defend. Then watch your strength, not just the scale, and you will know within a month whether what you are losing is fat or muscle.

FAQ

Do you lose muscle on Ozempic or Wegovy?

Some, yes. In the semaglutide body-composition data, roughly 40% of the weight lost registered as lean mass, higher than the 25% or so a slower diet costs. The drug does not target muscle; the speed of the loss does. Resistance training, adequate protein, and a slower rate of loss sharply reduce how much muscle you give up.

How do I keep muscle while on a GLP-1?

Three levers. Do resistance training in whatever form you will stick to, so the body has a reason to keep the muscle. Eat enough protein, roughly 1.6 to 2.2 grams per kilogram of bodyweight, which is hard because the drug kills your appetite. And keep the rate of loss slow, which is partly a dose decision. All three together protect far more lean mass than any one alone.

How much protein should I eat on a GLP-1?

Aim for about 1.6 to 2.2 grams per kilogram of bodyweight per day. The evidence for preserving lean mass climbs with protein up to around 1.6 g/kg when combined with resistance training. The challenge on a GLP-1 is that appetite suppression makes hitting any protein target harder, so it usually takes planning rather than waiting until you feel like eating.

Does a lower GLP-1 dose protect muscle?

Indirectly, yes. A lower or moderate dose tends to slow the rate of weight loss, and slower loss preserves more lean mass than rapid loss at the same endpoint. It is not that the dose acts on muscle directly; it is that a gentler rate of loss is easier to defend with training and protein. Dose decisions belong with your prescriber.

Will I regain the weight when I stop a GLP-1?

Often, yes. Most of the weight tends to return after stopping, especially if appetite rebounds and no new habits are in place. This is the argument for using the time on the drug to build durable eating and training habits and to protect muscle, since those are what carry the maintenance once the drug is gone.

Is there a weight-loss drug that builds muscle?

Not an approved one yet. Bimagrumab, which blocks the activin receptor, added lean mass while cutting fat alongside semaglutide in a 2026 trial, but it is investigational and one large program was halted, so it is a compound to watch rather than use. For now, resistance training and protein remain the proven way to keep muscle while losing fat.

How do I know if I’m losing muscle or fat on a GLP-1?

Do not trust the scale, which counts both the same. Track your strength in a few key lifts, your waist measurement, and a consistent body-fat estimate over months. Strength holding or rising while weight falls means your muscle is intact. Falling strength alongside a dropping scale is the warning sign that too much of the loss is muscle.

Sources